the present study aimed to investigate whether different lipid carriers increased bacterial growth in propofol and Propofol-Lipuro preparations without an antimicrobial agent. these agents were inoculated with seven different microorganisms in an experimental environment, and bacterial growth amounts and growth times over different periods were compared for each type of microorganism.
MEtHodS this study was approved by the ethics committee of Ankara training and research Hospital on July 24, 2013 (no: 513-4293). the effects of Propofol 1% (Fresenius Kabi, Graz, Austria) and Propofol-Lipuro 1% (B. Braun, Melsungen, Germany) on microorganismal growth were compared after experimental contamination with seven different types of microorganisms. Poliflex 0.9% isotonic sodium chloride solution (Polifarma, Istanbul, turkey) was used as the control.
the selection of microorganism species was based on two important factors: representation of different groups and having been isolated as anesthesia-rooted infection agents in previous studies (8) (9) . Based on these criteria, the microorganisms included in the study were methicillin-resistant Staphylococcus aureus (MrSA), methicillin-sensitive Staphylococcus aureus (MSSA), Staphylococcus epidermidis, Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa, and Serratia marcescens. the microorganisms were seeded in 5% sheep blood agar (or-BAK, Ankara, turkey), and reproduction of plaques was enabled by incubating for 24 h at 36°c. Plaques were evaluated for single-type reproduction at the end of incubation period. the bacterial suspension of 0.5% McFarland (0.5 x 10 8 cFu/ mL concentration) was prepared using 1 mL of 0.9% sterilized physiological serum (PS) in tapped sterilized glass tubes for each microorganism after confirming the purity of reproduction in the plaques. A McFarland gauge was used to evaluate the concentration.
next, 5 mL of sterilized PS was prepared in another sterilized glass tube for each microorganism. A dilution of 1:50 was achieved by adding 100 µL from the first tube after vortexing, and bacterial suspensions in a dilution of 10 6 cFus/mL were obtained. Microorganism suspensions (0.1 mL) from each microorganism were taken after vortexing, and three different groups were generated by inoculating the suspensions with 10-mL physiological serum (PS group (control group)), Propofol-Lipuro (PL group), and propofol (P group) in three different tubes. the obtained concentration was 10 4 cFus/mL after generating a 1:100 dilution. Each suspension was vortexed for 1 min after adding the microorganisms. then, 0.01-mL plantation was performed in 5% sheep blood agar medium. the suspensions were preserved at 20°c. Vortexing and plantation procedures were repeated after 4, 8, 24 , and 48 h. the quantitative growth amount was evaluated after incubation for 24 h at 36°c in the sheep blood agar medium.
Statistical analysis
the Statistical Package for the Social Sciences for Windows 19.0 was used for the statistical analyses of results. descriptive statistics (mean and standard deviation) were obtained in the evaluation of the study data, and variant analysis (repeated-measures test) was used in repeated measurements of two agents in the comparison of the intergroup follow-up times and cFu level between the groups. the group differences were determined using the least significant difference test at the end. the results were evaluated at a 95% confidence interval and significance of P < 0.05. rESuLtS A significant difference was detected with respect to the cFu level in repeated measurements of two factors with variant analysis (P < 0.001). A difference was detected in the intragroup time cFu levels (P = 0.040) (table 1). Statistically significant differences were detected in the cFus/mL levels between groups PS and PL, and groups PS and P (P = 0.020 and P = 0.002); however, no statistically significant difference was detected between groups PL and P (P = 0.259) (table 2).
the bacterial growth quantities were demonstrated after taking the logarithm of the cFu levels in the three groups. no significant change was observed in the numbers of MrSA and MSSA in the PS group considering the cFus/mL levels with time; however, a decrease in the number of S. epidermidis and an increase in other bacteria were detected ( Figure 1 ).
Propofol-Lipuro did not increase the reproduction amount of MrSA and MSSA at the end of 48 h in the PL group ( Figure 1A and 1c ). Significant increases in the numbers of colonies of S. epidermidis, E. coli, K. pneumonia, and S. marcescens were observed, particularly after 8 h in the reproduction curve ( Figure 1B and 1d-1F). A difference was detected in the reproduction graphics of P. aeruginosa compared with other microorganisms. Although an increase was noted during 0-4 h in the other groups, the period was stable in P. aeruginosa. Followed by a stable period, increased reproduction levels of P. aeruginosa were found during 4-8 h and 24-48 h ( Figure 1G ).
An increase was seen in all microorganisms in the P group at the end of 48 h. the comparison of the cFus/mL levels of MrSA according to time showed an increase until 4 h in the P group compared with the PL group. However, no increase was detected in the PL group. A decrease in the P group and an increase in the PL group was detected between 4 and 8 h. the increase continued in the P group after 24 h. However, a decrease was detected in the PL group ( Figure 1A) . the reproduction curves of S. epidermidis, MSSA, E. coli, K. pneumonia, and P. aeruginosa were similar in both propofol formulations (Fig. 1B-1E and 1G ). the reproduction curve of S. marcescens showed an increase in both groups at the end of 24 h; however, the increase in reproduction and stable periods during 0-4, 4-8, and 8-24 h differed ( Figure 1F ).
dIScuSSIon
Propofol and Propofol-Lipuro, which have been used in anesthesia practice, have been known to behave as a medium facilitating the reproduction of microorganisms due to their chemical characteristics (10, 11, 12) . A report released in the united States in 1990 by the centers for disease control indicated that extrinsic contamination of propofol was possible; therefore, it recommended the aseptic use of drug, immediate administration of drug after opening in sterile conditions, and use of ampule content within 6 h or dispose (13). Studies conducted in subsequent years particularly recommended the preservation of propofol formulations in sterilized and closed-end injectors rather than as open ampules, in addition to the previous recommendations (14).
Sosis et al. investigated the growth of S. aureus in bactericide-free sheep blood agar containing propofol, thiopental, methohexital, etomidate, and 0.9% saline during 0-3, 6-6, 6-21, 21-24, and after 27 h, and reported that only propofol had a perfect environment for the rapid growth of S. aureus (15) . Similar to the study by Joubert et al., PS was used as the control group in this study (16) . no significant increase was detected compared with the initial colonization levels in the PS group after 4, 8, and 24 h; however, a significant increase was detected in the number of colonies after 48 h.
three induction agents (propofol, thiopental, and alfaxalone) were investigated in a previous study, and it was observed that S. aureus and E. coli rapidly reproduced in propofol solution after 6 h, and the reproduction of E. coli was very rapid after 24 h (14) , consistent with the results of the present study regarding the colonization trend in E. coli.
Apan et al. found that the growth of E. coli was less affected compared with other agents when an agent known to inhibit E. coli reproduction (remifentanil) was added to propofol. they emphasized that the lipid content of propofol highly facilitated bacterial growth, and attentive aseptic conditions must be observed while using propofol to avoid any possible contamination (17) . A study investigating how heat and the inclusion of lidocaine into propofol affected bacterial contamination showed that less bacterial growth was detected in samples preserved in sterilized injectors compared with those preserved as open ampules. Lidocaine and heat did not significantly change the bacterial growth, and injectors must be prepared for single use only (18).
Yamakage et al. contaminated two different propofol products, one with and one without EdtA, at 20°c-25°c in soybean or Sabouraud's agar using E. coli, S. aureus, P. aeruginosa, S. marcescens, B. cepacia, and c. albicans, and measured the cFu levels during 6-12, 12-24, and 48 h. E. coli and B. cepacia reproduction was detected in the EdtA-containing formulation; however, S. marcescens reproduction was detected in both formulations. the authors concluded that although EdtA had a bactericidal effect, it could not completely inhibit the growth environment in propofol (19) . In this study, an increase in S. marcescens was observed at all time points. However, no change in the number of P. aeruginosa colonies was detected between 0-4 and 8-24 h; an increase in the number of colonies was detected during 4-8 h.
Zorrilla-Vaca et al. identified 58 studies conducted between 1989 and 2014 associated with propofol-related infections. they showed that propofol-associated hospital-acquired infections were a significant public health problem, and recommended that more observation and studies should be conducted to decrease the potential harm of contaminated propofol. they suggested that health workers must focus on hygiene precautions and prefer antimicrobial-containing propofol solutions to decrease contamination risk. the safe use of propofol would significantly improve outcomes (20) .
the recommendations for the use of propofol solutions have a significant role in anesthesia practice and must be followed as emphasized in the literature. the recommendations for use, particularly after 2005, included the use of 20 mL ampules in operating rooms, 50 mL flacons in intensive care units and one ampule for one patient. Furthermore, unused propofol solution should be disposed of, propofol solutions involving EdtA should be preferred, injection regions that are regarded to be a dead space region should be changed within 12 h, and health workers preparing the drugs should maintain proper hand hygiene (6, 12) (21).
concLuSIonS
A statistically significant increase was noted in the number of microorganism colonies in contaminated propofol and PropofolLipuro compared with PS. no statistically significant difference was detected between propofol and Propofol-Lipuro regarding the number of microorganism colonies, except with MrSA and MSSA.
An important limitation of the present study was that the test protocol was applied only once. the results of the present study would be more reliable if the test protocol is repeated three times. More studies should be conducted to investigate the nonsignificant difference in the reproduction quantity of MrSA and MSSA in the Propofol-Lipuro group, which has not been reported to date. In view of these results, the present study suggests the use of aseptic methods and administration in accordance with the updated recommendations in the literature while using propofol agents for decreasing contamination.
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